RxDataScience Inc. provides data science solutions for healthcare, focusing on advanced analytics for life science companies.

RxDataScience Inc.

RxDataScience  | 10,098 followers on LinkedIn. Pioneering life sciences transformation through AI, advanced analytics, and data science | RxDataScience Inc, a Syneos Health company, offers transformational end-to-end advanced data analytics and AI solutions and services for biotech, pharmaceutical and healthcare companies. Our team of advanced data experts use their years of healthcare industry knowledge to create agile data systems and platforms that help our customers reimagine processes and deliver game-changing insights across the asset lifecycle. We know that through advanced data science and AI, our solutions can greatly inform the work of life sciences companies and improve patients’ health.

Angel Investor, Startup Advisor, AI expert (ML, Generative AI, Digital Platforms, New Products)

Larry A. Pickett, Jr.

VP, Advanced Analytics | Generative AI & LLM | Tech Startup Funding | Healthcare & Finance

Nataraj Dasgupta

Senior Project Manager at RxDataScience Inc.

Heather Schraibman, PMP

AI Executive

Francis D'Souza

RxDataScience

🚀 The journey continued with an insightful session on Project and Portfolio Management in the Age of Generative AI! Nataraj Dasgupta , VP Advanced Analytics, RxDataScience a Syneos Health shared how AI is transforming operations and enhancing productivity. We learned how Syneos Health, the world’s third-largest CRO, utilizes innovative solutions like Protocol Nexus and Dynamic Resource Allocation to set new standards in project management efficiency. Embracing these technologies is crucial for success in the evolving pharma landscape! #GenerativeAI #ProjectManagement #Innovation #Pharma

Why Summits

🌟💼 In the next session on "Project and Portfolio Management in the Age of Generative AI," attendees gained valuable insights into the practical application of AI in project and portfolio management (PPM). Nataraj Dasgupta , VP Advanced Analytics at RxDataScience a Syneos Health Company, shared how AI, including Generative AI, is streamlining operations, reducing costs, and improving project timelines and productivity. Nataraj showcased real-world examples of how Syneos Health, a leading CRO, is utilizing Generative AI to transform traditional PPM processes. 🚀📈 #PPM #SanFrancisco #AIinPPM #GenerativeAI #Innovation #Efficiency

🌟🤖 Taking innovation to the next level, the Panel Discussion "The Art of the New Possible: Leading PMOs in the Era of Machine Learning and AI" sparked a lively debate. Christopher Vandepas , Director of Portfolio Program Management at Guardant Health , Joe Stalder , VP of Program Management at Zentalis Pharmaceuticals , SHOBA GOPALAN , Vice President of Program and Alliance Management at Synthekine , Ravindra S., Managing Director at RxDataScience and Karin Klemencic , Head of Site Business & Computerized Systems at Boehringer Ingelheim , explored how life science PMOs can leverage AI to reduce cycle times, lower costs, and eliminate launch delays. Panelists tackled the challenges of uniting diverse functional groups, overcoming disconnected tools, and addressing capability gaps using ML, AI, and APIs to streamline research, development, and launches. 🧩🔬 #PPM #SanFrancisco #AIinPharma #PMOInnovation #MachineLearning #PharmaLeadership

Struggling to compliantly and effectively implement AI and Gen AI in your organization? Or don't know where to start? Unlock the power of AI and machine learning for your life science company with Rapid AI Lab (RAIL) from RxDataScience. Our 4 to 12-week program offers fast, effective solutions to your most critical business challenges. Don't have an in-house data team? No problem--we've got you covered. Learn more about how we can help you stay ahead in the rapidly evolving pharmaceutical industry. 🚀💡 https://lnkd.in/eQv-gqYq #GenAI #AI #ML #MachineLearning #Pharma #Innovation #DataScience #LifeSciences #Healthcare

We hope to see you at the Why Summits American Pharma and Biotech Project, Program, and Portfolio Management (PPM) Conference in San Francisco where clinical portfolio professionals will have access to cutting-edge tools, insights, and organizational strategies to enhance strategic decision-making, optimize portfolio prioritization and resource planning, and foster value and resilience in your organization. Nataraj Dasgupta will be speaking on the topic of PPM in the Age of Generative AI and showing practical examples of how clinical project and portfolio teams are using this technology in their organizations today. Register today and save 70% with code SYNEOSVIP. Registration includes access to this presentation + full conference access June 6-7. We look forward to seeing you in San Francisco! Register & see the full agenda here: https://lnkd.in/eaJqda8j

We are looking forward to discussing how we are accelerating efficiencies and effectiveness for Clinical Development Project & Portfolio Management in San Francisco! Use code SYNEOSVIP to save 70% registration: https://lnkd.in/gFAFc33M

We are looking forward to attending the Pharmaceutical Management Science Association (PMSA) 2024 Annual Conference next week in Denver, CO! We hope to see you there for our poster presentation, "Generative AI for Clinical Trial Recruitment and Protocol Optimization" Monday afternoon. Connect with the team during the conference to learn more about how #RxDataScience and #SyneosHealth are shaping the future of pharma through AI and advanced analytics: https://lnkd.in/eUsGd67i #PMSA2024 #GenAI #ClinicalTrials Nataraj Dasgupta Francis D'Souza Ravindra Shukla Preethi Ravula

Last week the #RxDataScience team attended the Why Summits American Pharma and Biotech Project, Program, and Portfolio Management (PPM) Conference in Philadelphia where we came away with a treasure trove of insights and connected with a host of brilliant minds. Our VP of Advanced Analytics, Nataraj Dasgupta , shared how we are applying Gen AI to better enable PPM and clinical trial operations. If you missed the presentation or would like to learn more, let's talk!

Check out the latest Syneos Health Podcast where Darren Coleman explores the convergence of Wall Street and Formula One technology with the world of pharma through the combination of RxDataScience Inc. clinical trial AI-driven application expertise with KX technology to optimize site selection, predict enrollment rates, and identify trial risks well in advance. Listen to the podcast episode here: https://lnkd.in/dyngY-g3 #ClinicalTrials #HealthcareInnovation #KXTechnology #LifeSciences #Pharmaceuticals #PodcastEpisode #SyneosHealth

2024 is a year where leaders will excel in AI by cultivating expertise, and embracing innovative and socially responsible technologies. Emphasizing proper education, governance, and validation measures are crucial for success. Learn more: https://lnkd.in/eRdGwspD #SyneosHealth #2024HealthTrends

Metric
Company Name	RxDataScience Inc.
Symbol
MSH ID	COM:RXDATASCIENCE
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Health Technology
Country	US
Stage
Employee Count
Website	rxdatascience.com
LinkedIn	rxdatascience-inc.
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

RXDA

COM:RXDATASCIENCE

RxDataScience Inc.

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue